Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 81 - 100 of 218
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jul 2015, 6:41 am by Ellen Houston
Merrell Dow Pharmaceuticals, Inc., the landmark case that sets forth the test for the admissibility of expert testimony. [read post]
6 May 2013, 5:16 am by Susan Brenner
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
5 May 2007, 1:32 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) (”Daubert I”), on remand, 43 F.3d 1311 (9th Cir.) [read post]
8 May 2020, 3:47 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [2]  Frye v. [read post]
27 Dec 2012, 5:07 am by Erin Kristofco
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593-94 (1993) are relevant to the Court’s reliability determination under CRE 702, which is identical to FRE 702. [read post]
28 Dec 2017, 2:18 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
9 Jun 2015, 5:54 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), and (3) the testimony assists the trier of fact through the application of scientific, technical, or other specialized expertise. [read post]
19 Sep 2011, 6:20 am
Merrell Dow Pharmaceuticals are meant to prevent theories based on shaky science from cluttering up court proceedings and confusing juries. [read post]
18 Jan 2008, 2:34 am
Merrell Dow Pharmaceuticals, Inc. [read post]
18 Jan 2008, 2:34 am
Merrell Dow Pharmaceuticals, Inc. [read post]
21 Oct 2017, 9:00 am by W.F. Casey Ebsary, Jr.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]